[A case of advanced breast cancer receiving combination therapy with 5'-DFUR and MPA with remarkable results]

M Nishibe; H Kuribayashi; T Sato; I Watanabe; H Nishihara

[A case of advanced breast cancer receiving combination therapy with 5'-DFUR and MPA with remarkable results]

Gan To Kagaku Ryoho. 1997 Jul;24(9):1149-52.

[Article in Japanese]

Authors

M Nishibe¹, H Kuribayashi, T Sato, I Watanabe, H Nishihara

Affiliation

¹ Dept. of Surgery, Nakashibetsu Municipal Hospital.

PMID: 9239169

Abstract

A 75-year-old woman was admitted to our hospital with advanced breast cancer (T4bN3M0, Stage IIIb). She received chemoendocrine therapy of 5'-DFUR 800 mg/day and MPA 800 mg/ day for 2 months. The main tumor and metastatic lymph nodes were remarkably reduced and became resectable. Histological examination revealed necrotic change of the tumor tissues. This combination therapy proved very useful for advanced breast cancer.

Publication types

Case Reports
English Abstract

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Breast Neoplasms / drug therapy*
Breast Neoplasms / pathology
Breast Neoplasms / surgery
Carcinoma, Papillary / drug therapy*
Carcinoma, Papillary / secondary
Carcinoma, Papillary / surgery
Combined Modality Therapy
Drug Administration Schedule
Female
Floxuridine / administration & dosage
Humans
Lymph Node Excision
Lymphatic Metastasis
Medroxyprogesterone Acetate / administration & dosage

Substances

Floxuridine
Medroxyprogesterone Acetate
doxifluridine